Thu, Apr 27, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Switzerland's 116 hedge fund offices - where are they based? How Pfaeffikon is catching up with Geneva, Zurich

Friday, February 26, 2010

Benedicte Gravrand, Opalesque London:

For those thinking of opening up an office in Switzerland, a small town in the center of the country, with Lake Zurich’s in front and the Alpine mountains on the back, already has a claim on the finance – and especially the hedge fund – world. This town, where the 7000 or so inhabitants speak Swiss-German - and English, I am told - is Pfaeffikon. And it is at the moment in the midst of a boom, with building grounds and projects, as it is preparing to welcome an even greater international community.

Some of the firms that either have an office or head-quarters in Pfaeffikon or the area are:

- Man Group, one of the biggest listed hedge fund groups, which manages around $42bn; - LGT Capital Management, a traditional asset manager with around CHF16.8bn, and the affiliated LGT Capital Partners, an alternative asset manager with $18bn in AuM; - Horizon 21, an independent investment manager managing $8.4bn; - Aeris Capital, a private equity fund and financial advisor with $3bn; - Quaesta Capital, an independent financial services provider specialized in FX managing CHF1bn; - Mercury Forex, a currency manager; - 47 Degrees North Capital Management, a specialist alternative investment firm formed by nine former RMF and Man Investment analysts; - Swiss Alpha, a quant hedge fund manager with $120m; - Constellation Capital Advisors, another quant hedge fund manager; - True North Capital AG, ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V